[1] Lindahl B, Mills NL.A new clinical classification of acute myocardial infarction[J]. Nat Med, 2023,29(9):2200-2205.
[2] Wang X, Gao M, Zhou S, et al.Trend in young coronary artery disease in China from 2010 to 2014: a retrospective study of young patients≤45[J]. BMC Cardiovasc Disord, 2017,17(1):18.
[3] Gulati R, Behfar A, Narula J, et al.Acute Myocardial Infarction in Young Individuals[J]. Mayo Clin Proc, 2020, 95(1):136-156.
[4] Sagris M, Antonopoulos AS, Theofilis P, et al.Risk factors profile of young and older patients with myocardial infarction[J]. Cardiovasc Res, 2022, 118(10):2281-2292.
[5] Doughty M, Mehta R, Bruckman D,et al.Acute myocardial infarction in the young--The University of Michigan experience[J]. Am Heart J, 2002, 143(1):56-62.
[6] Khamis RY, Ammari T, Mikhail GW.Gender differences in coronary heart disease[J]. Heart, 2016, 102(14):1142-1149.
[7] Matsis K, Holley A, Al-Sinan A, et al.Differing Clinical Characteristics Between Young and Older Patients Presenting with Myocardial Infarction[J]. Heart Lung Circ, 2017, 26(6):566-571.
[8] Hubert HB, Feinleib M, McNamara PM, et al.Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study[J]. Circulation, 1983, 67(5):968-977.
[9] Kannel WB, Abbott RD.Incidence and prognosis of unrecognized myocardial infarction. An update on the Framingham study[J]. N Engl J Med, 1984, 311(18):1144-1147.
[10] Barbash GI, White HD, Modan M, et al.Acute myocardial infarction in the young--the role of smoking. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial[J]. Eur Heart J, 1995, 16(3):313-316.
[11] Yusuf S, Hawken S, Ounpuu S, et al.INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study[J]. Lancet, 2004, 364(9438):937-952.
[12] Oliveira A, Barros H, Azevedo A, et al.Impact of risk factors for non-fatal acute myocardial infarction[J]. Eur J Epidemiol, 2009,(8):425-32.
[13] Dimitrova IN.Acute Myocardial Infarction in Young Individuals: Demographic and Risk Factor Profile, Clinical Features, Angiographic Findings and In-Hospital Outcome.[J]. Cureus,2023, 15(9):e45803.
[14] McManus DD, Piacentine SM, Lessard D, et al. Thirty-year (1975 to 2005) trends in the incidence rates, clinical features, treatment practices, and short-term outcomes of patients <55 years of age hospitalized with an initial acute myocardial infarction[J]. Am J Cardiol, 2011, 108(4):477-482.
[15] Goliasch G, Oravec S, Blessberger H, et al.Relative importance of different lipid risk factors for the development of myocardial infarction at a very young age (≤ 40 years of age)[J]. Eur J Clin Invest, 2012, 42(6):631-636.
[16] Arbel Y.When will we learn that smoking is bad?[J]. Heart, 2017, 103(8):572.
[17] Ando H, Yamaji K, Kohsaka S, et al.Clinical Presentation and In-Hospital Outcomes of Acute Myocardial Infarction in Young Patients: Japanese Nationwide Registry[J]. JACC Asia, 2022, 2(5):574-585.
[18] Sood A, Singh A, Gadkari C.Myocardial Infarction in Young Individuals: A Review Article.[J]. Cureus,2023, 15(4):e37102.
[19] Rallidis LS, Xenogiannis I, Brilakis ES, et al.Causes, Angiographic Characteristics, and Management of Premature Myocardial Infarction: JACC State-of-the-Art Review[J]. J Am Coll Cardiol, 2022, 79(24):2431-2449.
[20] Zhang WP, Yuan ZY, Liu Y, et al.[Risk factors and coronary angiographic findings in young and elderly patients with acute myocardial infarction: a comparative analysis][J]. Nan Fang Yi Ke Da Xue Xue Bao, 2008, 28(5):718-721.
[21] Wiesbauer F, Blessberger H, Azar D, et al.Familial-combined hyperlipidaemia in very young myocardial infarction survivors (< or =40 years of age)[J]. Eur Heart J, 2009, 30(9):1073-1079.
[22] Zimmerman FH, Cameron A, Fisher LD, et al.Myocardial infarction in young adults: angiographic characterization, risk factors and prognosis (Coronary Artery Surgery Study Registry)[J]. J Am Coll Cardiol, 1995, 26(3):654-661.
[23] Hosseini SK, Soleimani A, Karimi AA, et al.Clinical features, management and in-hospital outcome of ST elevation myocardial infarction (STEMI) in young adults under 40 years of age[J]. Monaldi Arch Chest Dis, 2009, 72(2):71-76.
[24] Liang S, Liu H, Liu S, et al.Homocysteine induces human mesangial cell apoptosis via the involvement of autophagy and endoplasmic reticulum stress. RSC Adv.2019 Oct 7;9(54):31720-31727.
[25] Clarke R, Daly L, Robinson K, et al.Hyperhomocysteinemia: an independent risk factor for vascular disease[J]. N Engl J Med,1991, 324(17):1149-55.
[26] Akyürek Ö, Akbal E, Güneş F.Increase in the risk of ST elevation myocardial infarction is associated with homocysteine level[J]. Arch Med Res, 2014, 45(6):501-506.
[27] Ma Y, Peng D, Liu C, et al.Serum high concentrations of homocysteine and low levels of folic acid and vitamin B12 are significantly correlated with the categories of coronary artery diseases[J]. BMC Cardiovasc Disord, 2017, 17(1):37.
[28] Celermajer DS, Sorensen K, Ryalls M, et al.Impaired endothelial function occurs in the systemic arteries of children with homozygous homocystinuria but not in their heterozygous parents[J]. J Am Coll Cardiol, 1993, 22(3):854-858.
[29] Gokay S, Ciçek D, Müderrisoğlu H.Hyperhomocysteinemia in a young woman presenting with acute myocardial infarction: Case report[J]. Interv Med Appl Sci, 2013, 5(1):39-42.
[30] Nedelcu C, Ionescu M, Pantea-Stoian A, et al.Correlation between plasma homocysteine and first myocardial infarction in young patients: Case-control study in Constanta County, Romania[J]. Exp Ther Med, 2021, 21(1):101.
[31] Ogawa M, Abe S, Saigo M, et al.Homocysteine and hemostatic disorder as a risk factor for myocardial infarction at a young age[J]. Thromb Res, 2003, 109(5-6):253-258.
[32] Lee CW, Cheng TM, Lin CP, et al.Plasma haptoglobin concentrations are elevated in patients with coronary artery disease[J]. PLoS One, 2013, 8(10):e76817.
[33] Holme I, Aastveit AH, Hammar N, et al.Haptoglobin and risk of myocardial infarction, stroke, and congestive heart failure in 342,125 men and women in the Apolipoprotein MOrtality RISk study (AMORIS)[J]. Ann Med, 2009,41(7):522-32.
[34] Mohamed Bakrim N, Mohd Shah ANS, Talib NA, et al.Identification of Haptoglobin as a Potential Biomarker in Young Adults with Acute Myocardial Infarction by Proteomic Analysis[J]. Malays J Med Sci, 2020, 27(2):64-76.
[35] Chiang KH, Kao YT, Leu HB, et al.Higher post-acute myocardial infarction plasma haptoglobin level is associated with poor long-term overall survival[J]. Int J Cardiol, 2017, 229:102-107.
[36] Ambroziak M, Kuryłowicz A, Budaj A.Increased coagulation factor XIII activity but not genetic variants of coagulation factors is associated with myocardial infarction in young patients[J]. J Thromb Thrombolysis, 2019, 48(3):519-527.
[37] Balogh L, Katona É, Mezei ZA, et al.Effect of factor XIII levels and polymorphisms on the risk of myocardial infarction in young patients[J]. Mol Cell Biochem, 2018, 448(1-2):199-209.
[38] Redondo M, Watzke HH, Stucki B, et al.Coagulation factors II, V, VII, and X, prothrombin gene 20210G-->A transition, and factor V Leiden in coronary artery disease: high factor V clotting activity is an independent risk factor for myocardial infarction[J]. Arterioscler Thromb Vasc Biol, 1999, 19(4):1020-1025.
[39] Puy C, Rigg RA, McCarty OJ. The hemostatic role of factor XI. Thromb Res.2016 May;141 Suppl 2(Suppl 2):S8-S11.
[40] Egred M, Viswanathan G, Davis GK.Myocardial infarction in young adults[J]. Postgrad Med J, 2005, 81(962):741-745.
[41] Chami T, Kim CH.Cannabis Abuse and Elevated Risk of Myocardial Infarction in the Young: A Population-Based Study[J]. Mayo Clin Proc, 2019, 94(8):1647-1649.
[42] Pacher P, Steffens S, Haskó G, et al.Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly[J]. Nat Rev Cardiol, 2018, 15(3):151-166.
[43] Patel RS, Manocha P, Patel J, et al.Cannabis Use Is an Independent Predictor for Acute Myocardial Infarction Related Hospitalization in Younger Population[J]. J Adolesc Health, 2020, 66(1):79-85.
[44] DeFilippis EM, Singh A, Divakaran S, et al.Cocaine and Marijuana Use Among Young Adults With Myocardial Infarction[J]. J Am Coll Cardiol, 2018, 71(22):2540-2551.
[45] Moliterno DJ, Willard JE, Lange RA, et al.Coronary-artery vasoconstriction induced by cocaine, cigarette smoking, or both[J]. N Engl J Med, 1994, 330(7):454-459. |